Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
dc.contributor.author | Huang, X | |
dc.contributor.author | Yang, D | |
dc.contributor.author | Zhang, J | |
dc.contributor.author | Xu, J | |
dc.contributor.author | Chen, YE | |
dc.coverage.spatial | Switzerland | |
dc.date.accessioned | 2022-10-05T14:30:15Z | |
dc.date.available | 2022-10-05T14:30:15Z | |
dc.date.issued | 2022-07-01 | |
dc.identifier.issn | 2073-4409 | |
dc.identifier.issn | 2073-4409 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/35883629 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174880 | en |
dc.description.abstract | CRISPR–Cas9 is the state-of-the-art programmable genome-editing tool widely used in many areas. For safe therapeutic applications in clinical medicine, its off-target effect must be dramatically minimized. In recent years, extensive studies have been conducted to improve the gene-editing specificity of the most popular CRISPR–Cas9 nucleases using different strategies. In this review, we summarize and discuss these strategies and achievements, with a major focus on improving the gene-editing specificity through Cas9 protein engineering. | |
dc.format.medium | Electronic | |
dc.language | eng | |
dc.publisher | MDPI | |
dc.relation.haspart | ARTN 2186 | |
dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | CRISPR–Cas9 | |
dc.subject | gene editing | |
dc.subject | high fidelity | |
dc.subject | off-target | |
dc.subject | protein engineering | |
dc.subject | specificity | |
dc.subject | CRISPR-Associated Protein 9 | |
dc.subject | CRISPR-Cas Systems | |
dc.subject | Endonucleases | |
dc.subject | Gene Editing | |
dc.subject | Protein Engineering | |
dc.title | Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering | |
dc.type | Article | |
dc.identifier.pmid | 35883629 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174880/2/Recent Advances in Improving Gene-Editing Specificity through CRISPR-Cas9 Nuclease Engineering.pdf | |
dc.identifier.doi | 10.3390/cells11142186 | |
dc.identifier.doi | https://dx.doi.org/10.7302/6509 | |
dc.identifier.source | Cells | |
dc.description.version | Published version | |
dc.date.updated | 2022-10-05T14:30:11Z | |
dc.identifier.orcid | 0000-0002-1005-848X | |
dc.identifier.orcid | 0000-0003-2449-8651 | |
dc.identifier.orcid | 0000-0001-9452-2878 | |
dc.identifier.orcid | 0000-0003-2357-7825 | |
dc.identifier.volume | 11 | |
dc.identifier.issue | 14 | |
dc.identifier.startpage | 2186 | |
dc.identifier.name-orcid | Huang, X; 0000-0002-1005-848X | |
dc.identifier.name-orcid | Yang, D; 0000-0003-2449-8651 | |
dc.identifier.name-orcid | Zhang, J | |
dc.identifier.name-orcid | Xu, J; 0000-0001-9452-2878 | |
dc.identifier.name-orcid | Chen, YE; 0000-0003-2357-7825 | |
dc.working.doi | 10.7302/6509 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.